Dyslipidemia Drugs Global Market Analysis 2015 and Forecasts to 2023
Dyslipidemia Drugs Market - Global Industry Analys
Veröffentlicht am in "Business, Business", Sprache — English. 3 Seiten.
Dyslipidemia is a chronic metabolic syndrome, characterized by improper level of low density lipoprotein, high density lipoprotein, and triglycerides. This study on the dyslipidemia drugs market involves the analysis of a wide range of therapeutics that help patients to treat lipid disorders. Mehr anzeigen
